Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19

- Joint Procurement Agreement enables European countries to purchase bamlanivimab and etesevimab directly from Lilly, in varying quantities, based on local needs INDIANAPOLIS , Sept. 21, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a Joint Procurement Agreement with the